|
BMS-986165 phase 2 Trial results
|
Wed-10-10-2018, 08:54 AM
I tried to make sense of the figure, Caroline. It looks as if the placebo caused the biggest drop in lymphocytes. That seems wrong. The accompanying commentary suggested that what was being sought was a dosage that would suppress specific immune cells sufficiently without causing a neutropenia. The bar chart below the figure you posted looked more informative.
Cheers |
|
« Next Oldest | Next Newest »
|
| Messages In This Thread |
|
BMS-986165 phase 2 Trial results - by Fred - Tue-09-10-2018, 12:20 PM
RE: BMS-986165 phase 2 Trial results - by Caroline - Tue-09-10-2018, 17:49 PM
RE: BMS-986165 phase 2 Trial results - by Caroline - Tue-09-10-2018, 19:19 PM
RE: BMS-986165 phase 2 Trial results - by Bill - Wed-10-10-2018, 08:54 AM
|
| Possibly Related Threads… | |||||
| Thread | Author | Replies | Views | Last Post | |
|
CAL101 phase 1 on patients with psoriasis | Fred | 6 | 842 |
Fri-25-10-2024, 15:51 PM Last Post: Fred |
|
|
Piclidenoson for psoriasis phase 3 results | Fred | 1 | 3,235 |
Fri-02-02-2024, 20:04 PM Last Post: Caroline |
|
|
Skyrizi long term results for psoriasis | Fred | 16 | 5,755 |
Wed-10-01-2024, 21:16 PM Last Post: Caroline |
|
|
JNJ-2113 for psoriasis Phase 2b results | Fred | 4 | 3,486 |
Wed-12-07-2023, 11:52 AM Last Post: Turnedlight |
|
|
Tremfya for psoriatic arthritis phase 3b data | Fred | 0 | 1,486 |
Wed-31-05-2023, 16:26 PM Last Post: Fred |
Health Boards
